期刊文献+

Bmi-1蛋白在食管鳞状细胞癌中表达及临床意义 被引量:4

Expression and Clinical Significance of Bmi-1 Protein in Esophageal Squamous Cell Carcinoma
下载PDF
导出
摘要 目的:观察Bmi-1蛋白在食管鳞状细胞癌组织中的表达,探讨Bmi-1与食管鳞状细胞癌的相关性。方法:应用免疫组织化学法检测南京医科大学附属淮安第一医院2005年1月至2006年2月间168例食管鳞状细胞癌组织和30例正常食管黏膜组织Bmi-1蛋白的表达。结果:食管鳞状细胞癌组织和正常食管黏膜组织中Bmi-1蛋白的阳性表达率分别为66.1%(111/168)、23.3%(7/30),Bmi-1蛋白阳性表达率在食管鳞状细胞癌组织和正常食管黏膜组织中差异具有统计学意义(P<0.001),Bmi-1蛋白表达与食管鳞状细胞癌组织学分级、TNM分期和淋巴结转移具有相关性(P=0.016,P=0.004,P<0.001),Bmi-1阴性组的5年生存率显著优于Bmi-1阳性组(P<0.001)。结论:Bmi-1表达异常在食管鳞状细胞癌发生发展中具有重要作用,检测Emi-1的表达对判断食管鳞状细胞癌的预后具有重要意义。 To observe the expression and clinical significance of Bmi-l protein in esophageal squamous cell carcinoma ( ESCC ) and to discuss the correlation between the Bmi-l expression and ESCC. Methods: The expression of Bmi-l protein in 168 cases with the ESCC tissue and 30 with normal esophageal mucosa was determined through immunohistochemistry. Results: The expression rates of Bmi-l were 66.1% ( 111/168 ) and 23.3% ( 7/30 ) in the ESCC tissues and normal esophageal mucosa, respectively. Statistically significant differences were observed in the positive expression of Bmi-l between the ESCC and the normal mucosal tissues of the esophagus ( P 〈 0.001 ). The positive expression of Bmi-l in ESCC has been found to be related to the histological differentiation, TNM stages, and lymphatic metastases ( P = 0.016, P = 0.004, and P = 0.001 ). Moreover, the 5-year survival was superior in the Bmi-l-negative group than that in the Bmi-l-positive group ( P 〈 0.001 ). Conclusion: Bmi-l may play an important role in oncogenesis and progression of ESCC. Detection of the Bmi-l expression is important in evaluating the prognosis of ESCC.
出处 《中国肿瘤临床》 CAS CSCD 北大核心 2012年第13期911-913,共3页 Chinese Journal of Clinical Oncology
关键词 食管肿瘤 鳞状细胞癌 BMI-1 免疫组织化学法 Esophageal neoplasm Squamous cell carcinoma Bmi-l Immunohistochemistry
  • 相关文献

参考文献11

  • 1Cao L, Bombard J, Cintron K, et al. BMI1 as a novel target for drug discovery in cancer[J].J Cell Biochem, 2011, 112(10): 2729-2741.
  • 2朱爱华,陆华,肖新如,赵理,陈涛,刘伟,彭小忠,袁建刚,赵继宗.人脑胶质瘤中BMI1的表达及其意义[J].中国肿瘤临床,2009,36(11):640-643. 被引量:10
  • 3Sasaki M, Ikeda H, Itatsu K, et al. The overexpression of polycomb group proteins Broil and EZH2 is associated with the progression and aggressive biological behavior of hepatocellular carcinoma[J]. Lab Invest, 2008, 88(8): 873-882.
  • 4Xu CR, Lee S, Ho C, et al. Brnil functions as an oncogene independent of Ink4A/Arf repression in hepatic carcinogenesis[J]. Mol Cancer Res, 2009, 7(12): 1937-1945.
  • 5Dimri GP, Martinez JL, Jacobs JJ, et al. The Bmi-1 oncogene induces telomerase activity and immortalizes human mammary epithelial cells[J]. Cancer Res, 2002, 62(16): 4736-4745.
  • 6Cao R, Tsukada Y, Zhang Y. Role of Bmi-1 and ring1A in H2A ubiquitylation and Hox gene silencing[J]. Mol Cell, 2005, 20(6): 845-854.
  • 7Song LB, Zeng MS, Liao WT, et al. Bmi-1 is a novel molecular marker of nasopharyngeal carcinoma progression and immortalizes primary human nasopharyngeal epithelial cells[J]. Cancer Res, 2006, 66 (12): 6225-6232.
  • 8黄开红,刘建化,李学先,宋立兵,曾木圣,郭宝红.Bmi-1在胃癌组织中的表达及相关性研究[J].中国肿瘤临床,2007,34(17):961-965. 被引量:16
  • 9Wang H, Pan K, Zhang HK, et al. Increased polycomb-group ncogene Bmi-1 expression correlates with poor prognosis in hepatocellular carcinoma[J].J Cancer Res Clin Oncol, 2008, 134 (5):535-541.
  • 10Yu Q, Su B, Liu D, et al. Antisense RNA-mediated suppression of Bmi-1 gene expression inhibits the proliferation of lung cancer cell line A549[J]. Oligonucleotides, 2007, 17(3): 327-335.

二级参考文献32

  • 1刘卫红,孟秀香,刘丹丹,单路娟,赵心宇.反义Bmi-1对Jurkat细胞的抑制作用[J].中华血液学杂志,2005,26(9):554-556. 被引量:19
  • 2龚辉,张义成,刘文励.Bmi-1基因调控造血干细胞自我更新的研究进展[J].中国实验血液学杂志,2006,14(2):413-415. 被引量:11
  • 3冯艳,宋立兵,郭宝红,廖雯婷,李满枝,刘万里,曾木圣,张玲.Bmi-1在乳腺癌组织中的表达及意义[J].癌症,2007,26(2):154-157. 被引量:67
  • 4李连弟,鲁凤珠,张思维,牧人,孙秀娣,皇甫小梅,孙杰,周有尚,欧阳宁慧,饶克勤,陈育德,孙爱明,薛志福,夏毅.中国恶性肿瘤死亡率20年变化趋势和近期预测分析[J].中华肿瘤杂志,1997,19(1):3-9. 被引量:869
  • 5Leung C, Lingbeek M, Shakhova O, et al. Bmil is essential for cerebellar development and is overexpressed in human medulloblastomas[J]. Nature, 2004, 428(6980):337-341.
  • 6van Kemenade FJ, Raaphorst FM, Blokzijl T, et al. Coexpression of BMI-1 and EZH2 polycomb-group proteins is associated with cycling cells and degree of malignancy in B-cell non-Hodgkin lymphoma[J]. Blood, 2001, 97(12): 3896-3901.
  • 7Neo SY, Leow CK, Vega VB, et al. Identification of discriminators of hepatoma by gene expression profiling using a minimal dataset approach[]]. Hepatology,2004, 39(4): 944-953.
  • 8Kim JH, Yoon SY, Kim CN, et al. The Bmi-1 oncoprotein is overexpressed in human colorectal cancer and correlates with the reduced p16INK4a/p14ARF proteins[J]. Cancer Lett, 2004, 203 (2): 217-224.
  • 9KimJH, Yoon SY, Jeong SH, et al. Overexpression of Bmi-1 oncoprotein correlates with axillary lymph node metastases in invasive ductal breast cancer[J]. Breast, 2004, 13 (5): 383-388.
  • 10Brock HW, van Lohuizen M. The Polycomb group-no longer an exclusive club[J]? Curr Opin Genet Dev, 2001, 11(2): 175-181.

共引文献24

同被引文献67

  • 1Wang Y, Zhe H,Ding Z,et al. Cancer siena cell marker Bmi-1 expression is associated with basal like phenolype and poor sur rival in breast cancer[J]. World J Surg, 2012,36 (5):1189-1194.
  • 2Liu W,Feng JQ,Shen XM, et al. Two stem cell markers, ATP-binding cassette,G2 subfamily (ABCG2) and BMI-l,predict the transformation of oral leukoplakia to cancer: a long-term follow- up study[J]. Cancer,2012,118(6):1693-16700.
  • 3Bahl K, Saraya A,Sharma R. Increased Levels of Circulating and Tissue mRNAs of Oct-4, Sox-2, Bmi-1 and nanog is ESCC patients:Potential tool for minimally invasive cancer diagnosis[J]. Biomark Insights, 2012,7 : 27-37.
  • 4Kim J, Hwangbo J, Wong PK. p38 MAPK-Mediated Bmi-1 down- regulation and defective proliferation in ATM-deficient neural stem cells can be restored by Akt activation [J]. PLoS One, 2011,6 (1): e16615.
  • 5Min L, Dong-Xiang S, Xiao-Tong G, et al. Clinicopathological and prognostic significance of Bmi-1 expression in human cervical cancer [J]. Acta Obstet Gynecol Scand,2011,90(7):737-745.
  • 6Guo BH, Feng Y, Zhang R, et al. Bmi-1 promotes invasion and metastasis,and its elevated expression is correlated with an ad- vanced stage of breast cancer[J]. Mol Cancer,2011,10(1):10.
  • 7Lu YW,Li J,Guo WJ. Expression and clinicopathological signifi- cance of Mel-18 and Bmi-1 mRNA in gastric carcinoma[J]. J Exp Clin Cancer Res, 2010,29 : 143.
  • 8Yin T,Wei H,Leng Z,et al. Bmi-1 promotes the chemoresis- tance,invasion and tumorigenesis of pancreatic cancer cells[J]. Chemotherapy, 2011,57 (6) : 488-496.
  • 9Wang G,Liu L,Sharma S,et al. Bmi-1 confers adaptive radiore- sistance to KYSE 150R esophageal carcinoma cells[J]. Biochem Biophys Res Commun,2012,425(2) :309-314.
  • 10Lv J, Cao XF, Ji L, et al. Association of β-catenin, Wnt i, Smad4, Hoxa9,and Bmi-1 with the prognosis of esophageal squamous cell carcinoma[J]. Med Oncol,2012,29(1) :151-160.

引证文献4

二级引证文献24

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部